Firefly Neuroscience (formerly Elminda) sought a solution that was equipped to cover the different types of studies they needed to perform, and found the perfect partner in Greenlight Guru Clinical (formerly SMART-TRIAL).
Founded in 2006, Firefly Neuroscience (formely Elminda) provides clinicians with quantitative and object measurements to aid patients suffering from mental illnesses with brain mapping technology. Its brain network analytics technology provides an objective assessment of cognition.
Firefly Neuroscience is an inspiring brain-tech company addressing one of the ultimate challenges - understanding the human brain, paving a path for better brain health through BNA™ (Brain Network Activation) technology. The state-of-the-art BNA™ technology holds the potential to revolutionize the diagnosis, monitoring and treatment of brain-related disorders by measuring how effectively different parts of the brain are connecting and communicating.
Firefly Neuroscience's goal is to document the efficacy and safety of its brain network activation (BNA™) technology and to improve its product research and development programs. Hence, Firefly Neuroscience sought a solution that was equipped to cover the different types of studies they needed to perform.
Firefly Neuroscience now have an all-in-one solution that enables them to collect and manage all evidence based data. Greenlight Guru Clinical can be tailored to clinical study and post-market needs, as well as market and product research. Increased overview, flexibility, and integration possibilities with the BNA™ platform, are some of the great benefits that Firefly Neuroscience gets with Greenlight Guru Clinical.
''Firefly Neuroscience is a data-driven company and constantly aims to improve the quality and visibility of data. We believe that the Greenlight Guru Clinical data management platform will help us to achieve these mandatory goals.'' says Liran Korine
Director Clinical and Regulatory Affairs at Firefly Neuroscience.